Health economics is a branch of economics that studies how scarce resources are allocated in the production, distribution, and consumption of health and healthcare. It applies economic theory, models, and empirical techniques to analyze the behavior of individuals, healthcare providers, insurers, and governments in health-related markets. Unlike standard markets, healthcare markets are characterized by pervasive information asymmetries, externalities, moral hazard, and the ethical imperative that access to care should not be determined solely by ability to pay, making health economics a uniquely complex and policy-relevant field.
Central to health economics is the evaluation of costs and outcomes associated with medical interventions, public health programs, and health system designs. Tools such as cost-effectiveness analysis, cost-benefit analysis, and quality-adjusted life years (QALYs) allow analysts to compare the value delivered by competing uses of limited healthcare budgets. These methods inform decisions ranging from which drugs a national formulary should cover to how much a society should invest in preventive care versus curative treatment. Health economists also study the determinants of health beyond clinical care, including socioeconomic status, education, environmental factors, and behavioral choices.
The field has grown in policy importance as countries around the world confront rising healthcare expenditures driven by aging populations, technological innovation, and the growing burden of chronic disease. Health economists contribute to debates on universal health coverage, pharmaceutical pricing, hospital payment reform, and the design of health insurance markets. Whether evaluating the Affordable Care Act in the United States, single-payer models in Canada and the United Kingdom, or social health insurance in Germany and Japan, health economics provides the analytical framework for understanding trade-offs among efficiency, equity, and quality in health systems.